Filing Details
- Accession Number:
- 0001127602-19-005997
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-14 16:21:15
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-14 16:21:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-12 | 28,888 | $0.00 | 358,929 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-12 | 6,067 | $0.00 | 364,996 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-02-12 | 16,828 | $292.20 | 348,168 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-02-13 | 3,300 | $293.66 | 344,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Shares | Disposition | 2019-02-12 | 28,888 | $0.00 | 28,888 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,000 | Indirect | By Daughters |
Footnotes
- Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015.
- Represents additional shares of stock awarded as a result of the Company achieving at least 121% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015.
- The sale was made pursuant to a 10b5-1 plan.
- Balance includes 62 shares acquired through Employee Stock Purchase Plan.
Billionaire Hedge Funds
